163 related articles for article (PubMed ID: 38517989)
1. The Role of Epstein-Barr Virus (EBV) Infected Gastric Cancer in Increasing microRNA124 (miR-124) Promoter Methylation and Enhancer of Zeste Homolog 2 (EZH2) Gene Expression.
Ghoreshi ZA; Rezaei Zadeh Rukerd M; Askarpour H; Kheirkhah Vakilabad AA; Nakhaie M; Abbaszadeh Afshar MJ; Behboudi E; Charostad J; Arefinia N
Medicine (Baltimore); 2024 Mar; 103(12):e36534. PubMed ID: 38517989
[TBL] [Abstract][Full Text] [Related]
2. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
[TBL] [Abstract][Full Text] [Related]
3. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Changes in Gastric Carcinogenesis: Differential Dysregulation during
Prinz C; Mese K; Weber D
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921696
[TBL] [Abstract][Full Text] [Related]
5. Enhancer of zeste homolog 2 exerts functions in gastric cancer development via modulating microRNA-222-3p methylation and WEE1 expression.
Feng Y; Wang C; Shi T; Liu W; Liu H; Zhu B; Gao F
Chem Biol Drug Des; 2022 Sep; 100(3):320-333. PubMed ID: 35765903
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin.
Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC
mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958
[TBL] [Abstract][Full Text] [Related]
7. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells.
Sonkar C; Verma T; Chatterji D; Jain AK; Jha HC
BMC Cancer; 2020 Sep; 20(1):925. PubMed ID: 32993565
[TBL] [Abstract][Full Text] [Related]
8. Co-infection relationship with Epstein-Barr virus in gastroduodenal diseases with Helicobacter Pylori. Quantitative PCR and EBNA-1 gene-based approach.
Akkus S; Gareayaghi N; Saribas S; Demiryas S; Ozbey D; Kepil N; Demirci M; Ziver Snap T; Oyku Dinc H; Akcin R; Uysal O; Tugberk Bakar M; Talha Aygun M; Bahar Tokman H; Kocazeybek B
Acta Gastroenterol Belg; 2022; 85(2):301-308. PubMed ID: 35709774
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases.
Shukla SK; Prasad KN; Tripathi A; Singh A; Saxena A; Ghoshal UC; Krishnani N; Husain N
Braz J Infect Dis; 2011; 15(6):583-90. PubMed ID: 22218519
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 (TGF-β1) modulates Epstein-Barr virus reactivation in absence of Helicobacter pylori infection in patients with gastric cancer.
Shukla SK; Khatoon J; Prasad KN; Rai RP; Singh AK; Kumar S; Ghoshal UC; Krishnani N
Cytokine; 2016 Jan; 77():176-9. PubMed ID: 26239415
[TBL] [Abstract][Full Text] [Related]
12. The promoter aberrant methylation status of TMEM130 is associated with gastric cancer.
Zhang Y; Hu S; Li J; Shi D; Luo B
Dig Liver Dis; 2022 Jun; 54(6):819-825. PubMed ID: 34162508
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis.
Wu WK; Yu J; Chan MT; To KF; Cheng AS
J Pathol; 2016 Jul; 239(3):245-9. PubMed ID: 27102722
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.
Fukayama M; Hino R; Uozaki H
Cancer Sci; 2008 Sep; 99(9):1726-33. PubMed ID: 18616681
[TBL] [Abstract][Full Text] [Related]
15. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease.
Saxena A; Nath Prasad K; Chand Ghoshal U; Krishnani N; Roshan Bhagat M; Husain N
Scand J Gastroenterol; 2008; 43(6):669-74. PubMed ID: 18569983
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus and gastric carcinoma.
Fukayama M
Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
[TBL] [Abstract][Full Text] [Related]
17. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
[TBL] [Abstract][Full Text] [Related]
18. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
Geddert H; zur Hausen A; Gabbert HE; Sarbia M
Cell Oncol (Dordr); 2011 Jun; 34(3):209-14. PubMed ID: 21538028
[TBL] [Abstract][Full Text] [Related]
19. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
[TBL] [Abstract][Full Text] [Related]
20. The association between lncRNA H19 and EZH2 expression in patients with EBV-positive laryngeal carcinoma.
Hotoboc IE; Fudulu A; Grigore R; Bertesteanu S; Huica I; Iancu IV; Botezatu A; Bleotu C; Anton G
Acta Otorhinolaryngol Ital; 2021 Dec; 41(6):537-543. PubMed ID: 34825669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
